Development of a proteomic signature associated with severe disease for patients with COVID-19 using data from 5 multicenter, randomized, controlled, and prospective studies.
Castro-Pearson S, Samorodnitsky S, Yang K, Lotfi-Emran S, Ingraham NE, Bramante C, Jones EK, Greising S, Yu M, Steffen BT, Svensson J, Åhlberg E, Österberg B, Wacker D, Guan W, Puskarich M, Smed-Sörensen A, Lusczek E, Safo SE, Tignanelli CJ.
Castro-Pearson S, et al.
Sci Rep. 2023 Nov 20;13(1):20315. doi: 10.1038/s41598-023-46343-1.
Sci Rep. 2023.
PMID: 37985892
Free PMC article.